Atlas Trials

Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation

Clinical trial NCT02123108 · COMPLETED

Trial details

NCT number
NCT02123108
Sponsor
University of California, Los Angeles
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Liver Transplantation
Start date
2011-01-01
Primary completion
2015-01-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.